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ABSTRACT
Three-dimensional organization of chromatin is
fundamental for transcriptional regulation. Tissue-
specific transcriptional programs are orchestrated
by transcription factors and epigenetic regulators.
The RUNX2 transcription factor is required for
differentiation of precursor cells into mature os-
teoblasts. Although organization and control of the
bone-specific Runx2-P1 promoter have been stud-
ied extensively, long-range regulation has not been
explored. In this study, we investigated higher-
order organization of the Runx2-P1 promoter dur-
ing osteoblast differentiation. Mining the ENCODE
database revealed interactions between Runx2-P1
and Supt3h promoters in several non-mesenchymal
human cell lines. Supt3h is a ubiquitously expressed
gene located within the first intron of Runx2. These
two genes show shared synteny across species
from humans to sponges. Chromosome conforma-
tion capture analysis in the murine pre-osteoblastic
MC3T3-E1 cell line revealed increased contact fre-
quency between Runx2-P1 and Supt3h promoters
during differentiation. This increase was accom-
panied by enhanced DNaseI hypersensitivity along
with RUNX2 and CTCF binding at the Supt3h pro-
moter. Furthermore, interplasmid-3C and luciferase
reporter assays showed that the Supt3h promoter
can modulate Runx2-P1 activity via direct associa-
tion. Taken together, our data demonstrate physical
proximity between Runx2-P1 and Supt3h promoters,
consistent with their syntenic nature. Importantly, we
identify the Supt3h promoter as a potential regulator
of the bone-specific Runx2-P1 promoter.
INTRODUCTION
The Runt-related transcription factor 2
(RUNX2/CBF1/AML3) is essential for osteoblastic
differentiation and is required for bone and cartilage de-
velopment (1–5). A complete knockout of Runx2 leads to
embryonic lethality marked by an absence of bone develop-
ment and ossification (2,6,7). Moreover, RUNX2 interacts
with the nuclear matrix to affect histone modifications and
chromatin remodeling (8–10).
ThemurineRunx2 gene is located on chromosome 17 and
spans a region of ∼210 kb. Two predominant runx2 RNAs
are transcribed from distinct promoters. The runx2 type-
II transcript controlled by the P1 promoter is exclusively
expressed in osteo-progenitor cells and is stimulated upon
bone formation. The runx2 type-I transcript is driven by the
P2 promoter and is expressed in both osteogenic and non-
osteogenic mesenchymal tissues (11). During embryonic de-
velopment, P1 promoter driven runx2 type-II is the major
transcript expressed in the developing skeleton (12). Consis-
tent with this pattern, the specific loss of expression from the
Runx2-P1 promoter in mice results in severe developmental
defects with cleidocranial dysplasia (CCD)-like symptoms
(12).
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Runx2 displays a syntenic relationship with the suppres-
sor of Ty3 homolog (Supt3h) gene, whose promoter re-
sides within the first intron and ∼38 kb downstream of
the Runx2-P1 transcriptional start site (TSS). SUPT3H
is a TBP-associated factors (TAF)-associated protein that
is a component of the human histone acetyl transferase
STAGA complex (SPT3-TAF9-GCN5-acetylase) (13–16).
These two genes have different expression profiles; Runx2-
P1 is developmentally regulated, while Supt3h is ubiqui-
tously expressed and is essential in all tissues. Interestingly,
the syntenic relationship betweenRunx2 and Supt3h is con-
served among species from humans to sponges (17), which
suggests the existence of an evolutionarily conserved se-
lective pressure to preserve this syntenic relationship. This
pressure may be due to a shared or linked regulatory con-
trol mechanism and a potential for crosstalk between these
two genes (18,19).
In this study, we investigated the higher-order organiza-
tion of theRunx2 locus in several cell types.Mining the EN-
CODE database through the WashU Epigenome Browser
(20), we identified long-range associations between the
Runx2-P1 andSupt3h promoter regions. Carrying out chro-
mosome conformation capture (3C) analyses in RAW264.7
murine macrophage cells, whereRunx2-P1 is silent, we con-
firmed the existence of this interaction. As Runx2-P1 ac-
tivity is increased during osteoblastogenesis, we next asked
whether this interaction is dynamic and functional. Inter-
estingly, 3C analyses revealed an increase in the interac-
tion frequency between the Runx2-P1 and Supt3h promot-
ers in MC3T3-E1 murine pre-osteoblast cultures through-
out osteoblastic differentiation. The Supt3h promoter also
showed enrichment for DNaseI hypersensitivity (DHS) and
CCCTC-binding factor (CTCF) and RUNX2 localization
with the onset of osteogenesis. Finally, we provide evi-
dence that the Supt3h promoter can interact with Runx2-
P1 in-trans and modulate its expression in a differentiation-
dependent manner.
MATERIALS AND METHODS
WASHU epigenome and UCSC genome browser search
Online interaction data were obtained from the WASHU
epigenome browser (20) and the UCSC Genome Browser
(21). IMR90 HiC data (22) and the PolII ChIA-PET data
(23) were extracted for the hg19:chr6:45 250 000–45 370
000 genomic coordinates. The DHS tracks were obtained
for University of Washington (UW) tracks for MCF7 and
K562, and from Duke University tracks for IMR90. The
MCF7 CTCF ChIP-seq data were extracted from UW gen-
erated tracks. Both CTCF and PolII tracks were obtained
from Stanford/Yale/Duke/Harvard tracks for K562 and
IMR90 cells. TheMCF7PolII ChIP-seq data were obtained
from UT Austin tracks. All RNA-seq data were gathered
from theCold SpringHarbor Laboratory ENCODE tracks.
Cell culture
The MC3T3-E1 clone-4 pre-osteoblastic murine cell line
(24) was obtained from the American Type Culture Collec-
tion (ATCC, Manassas, VA). Growth-phase cultures were
maintained in -MEM without ascorbic acid (Hyclone,
Thermo Fisher Scientific, Rochester, NY) and supple-
mented with 1% penicillin-streptomycin (Gibco, Life Tech-
nologies, Grand Island, NY), 2 mM L-glutamine (Gibco,
Life Technologies, Grand Island, NY) and 10% fetal bovine
serum (Hyclone, Thermo Fisher Scientific, Rochester, NY).
When cultures reached ∼90% confluency, differentiation
was initiated by the addition of 142 M ascorbic acid
(Sigma-Aldrich, St Louis, MO). After 2 days, the ascorbic
acid concentration was increased to 280 M and 5 mM
-glycerophosphate (Sigma-Aldrich, St Louis, MO) was
added. Cultures were maintained at 37◦C and at 5% CO2.
Chromosome conformation capture (3C)
3C assays were performed as previously described (25,26),
with the following modifications: 3C restriction fragments
were defined by BglII enzyme digestion. The anchor frag-
ment used to query Runx2-P1 chromosomal interaction
spans from −975 to +1113 (mm9 chr17: 44 950 469–44
952 567). ∼1 × 108 MC3T3-E1 cells were fixed with 1%
formaldehyde in serum free -MEM for 10 min at room
temperature. Formaldehyde was quenched by the addition
of 0.125 M glycine. Nuclei were released by Dounce ho-
mogenization in ice-cold lysis buffer (10 mM Tris-HCl pH
8.0, 10 mMNaCl, 0.2% NP-40) containing cOmplete, Mini
Protease Inhibitor Cocktail (Roche Applied Science, In-
dianapolis, IN). Nuclei were collected and subjected to
overnight digestion with 400 U of BglII (New England Bi-
oLabs, Ipswich, MA). The enzyme reaction was halted by
incubation at 65◦C for 30min in the presence of 10% sodium
dodecyl sulphate. Samples were aliquoted into 22 separate
tubes and were diluted 40-fold in ligation buffer (25) and
subjected to proximity-mediated ligation with 10 U of T4
DNA Ligase (Invitrogen, Life Technologies, Grand Island,
NY) per reaction for 4 h at 16◦C. Nuclear material was re-
verse cross-linked by overnight incubation with Proteinase
K at 65◦C. Ligated chromatin was extracted by phenol-
chloroform extraction followed by ethanol precipitation.
3C primers that span the Runx2 gene locus were designed
by Primer3 software and are listed in Supplementary Table
S1. The annealing temperatures of all 3C primers were 60±
1◦C. The polymerase chain reaction (PCR) conditions were
95◦C for 8 min followed by 35 cycles of 95◦C for 30 s, 60◦C
for 30 s and 72◦C for 30 s, followed by 72◦C for 8 min. All
3C PCR products were analyzed on 1% agarose gels stained
with ethidium bromide. Gel quantifications were analyzed
using the GEL-QUANT software (www.gelquant.org).
Interaction frequencies were determined by assessing
fold-change of 3C PCR amplification product of sam-
ple chromatin compared to randomly ligated BglII di-
gested bacterial artificial chromosomes (BACs) that span
the Runx2 locus. The following BAC clones, which span
the Runx2-Supt3h locus and a gene desert region, were
used: BACPAC CHORI (Children’s Hospital Oakland
Research Institute) catalog numbers RP23-22H7, RP23-
92H18, RP23-356F5, RP23-443F11, andRP23-238O6. The
ligation efficiencies of all 3C samples were normalized to
each other by taking the log2 average of the ligation fre-
quencies of a gene desert region (27) for samples gener-
ated with BglII, and ERCC3 locus for samples generated
with HindIII. The BAC control template was prepared by
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mixing the different BACs in equimolar concentrations,
followed by digestion and ligation. Then, the interaction
frequency was calculated by dividing the amount of PCR
product from the 3C template by the amount of PCR prod-
uct from the BAC control template, thereby normalizing
for differences in primer efficiencies. All of the 3C primer
pairs yielded similar amounts of product with both the 3C
and the BAC templates. Primers that gave very low PCR
yields were discarded. 3C data represent the averaged liga-
tion frequencies of two independent cultures quantified in
three separate library preparations. Student’s t-test was used
to assess the P values.
DNase-seq
Genome-wide DNase-hypersensitivity mapping of os-
teoblast cultures was performed by adapting theDNase-seq
protocol from Song et al. (28) with slight modifications. Ap-
proximately 40× 106 growth-phase (day 0 or d0) or matrix-
deposition stage (day 9 or d9) MC3T3-E1 cells were har-
vested and were each subjected to 4, 12 and 40 U/l of
DNaseI for 15 min at 37◦C. Steps involving the isolation
of chromatin embedded in agarose included a treatment
with 10 U/ml -agarase for 2 h at 37◦C before extracting
with phenol:chloroform:isoamyl alcohol (25:24:1 v/v) and
ethanol precipitation. Peak signals in this report represent
a single biological sample for each culture condition se-
quenced twice (combined technical duplicates) and normal-
ized using align2rawsignal (A. Kundaje, http://code.google.
com/p/align2rawsignal/). DNase-seq analysis was validated
by 4-fold representation (two biological replicates, each
with technical duplicates) that passes ENCODE Consor-
tium standards on F-seq called peaks (29) using IDR anal-
ysis (data not shown; (40)). The DNase-seq data were de-
posited under the accession GSE55046.
Reverse-transcriptase qPCR
Total RNA from cultures was extracted using TRIzol
reagent (Invitrogen, Life Technologies, Grand Island, NY)
followed by DNase treatment with DNA-Free RNA Kit
(Zymo Research, Irvine, CA) according to manufacturer’s
instruction. cDNA was prepared using the SuperScriptIII
First-Strand Synthesis System (Invitrogen, Life Technolo-
gies, Grand Island, NY). qPCR was performed with the
iTaq SYBR Green Supermix with ROX (Bio-Rad, Her-
cules, CA) and on the 7300 Sequence Detection System
(Bio-Rad Laboratories, Hercules, CA). Relative transcript
levels were determined by the Ct method and normal-
ized to gapdh. Primer sequences for runx2P1, runx2P2,
osteocalcin, bone sialoprotein and gapdh are described
elsewhere (12). Primers for detection of supt3h message
were designed using FoxPrimer (www.foxprimer.org; Dob-
son et al., manuscript in preparation) and are: forward,
5′-AAGGCATTGACGAGGATGAC-3′ and reverse, 5′-
TCTTCAAACATTGCCAGCAG-3′. Student’s t-test was
used to assess the P values.
Reporter constructs
The design and preparation of the 3-kb (−2821 to−16) and
0.6-kb (−629 to −16) luciferase constructs are described
elsewhere (30). The Runx2-P1 0.9-kb Luc construct was
derived from the 3-kb luciferase construct by deleting se-
quence between −2821 and −966 using the quick-change
method for large fragment deletion (30). The murine 3.3-
kb Supt3h promoter region (3315 bp) was PCR cloned
from mouse C57BL/6 genomic DNA using Phusion High-
Fidelity DNA Polymerase using the following forward and
reverse primers: 5′-GCTCGCACTCAGCTTTGGGCA-
3′ and 5′-GGGAGAGACAGGCAAGGAGGGG-3′. The
3.3-kb Supt3h promoter region flanked by KpnI restric-
tion sites was cloned upstream of 0.9-kb Runx2-P1 pGL3
luciferase vector (GENEWIZ, Inc., South Plainfield, NJ).
To generate the Supt3h-TOPO construct, the 3.3-kb Supt3h
promoter region was subcloned into the pCR-4Blunt-
TOPO vector using the Zero Blunt TOPOPCRCloningKit
following manufacturers’ recommended conditions. The
Supt3h-DHS1 and Supt3h-DHS2 TOPO and 0.9-kb pGL3
constructs described here were generated by similar meth-
ods using the following primer sets:
Supt3h-DHS1:FW, 5′-GGA ACT TTG TAG AAA GGA
ACGGGGG-3′,RV,5′-CATGCGCACCCGGCTGGC
C-3′; Supt3h-DHS2:FW, 5′-CGC TCT CGC CGC ACG
GC-3′,
RV, 5′-CTC CCA TAA ACC TGA GTT TTG AGC TAG
G-3′; Supt3h-0.5 kb: FW, 5′-GAT ATT AGT TGA GCA
GAA TTT TAA T-3′, RV, 5′-TAC TTC ATT AAT GTC
TTG CCT ATG-3′
Supt3h-0.6 kb:FW, 5′-TAA CTT CAC AAG AGC TTC
GTT TTC-3′, RV 5′ TAA ACA AAC AAA CAA ACA
AAC TGC T-3′; Supt3h-1.1 kb:FW 5′TAA CTT CAC
AAG AGC TTC GTT TTC-3′, RV 5′-TAC TTC ATT
AAT GTC TTG CCT ATG-3′.
The empty-TOPO construct described in this report was
generated by allowing the pCR-4Blunt-TOPO vector to
self-circularize, a low-frequency event that occurs when re-
actions lack a blunt-ended fragment. The TK-pGL3 and
SV40-renilla constructs were kind gifts fromDr Stephen D.
Hauschka.
Co-transfections and Luciferase reporter assays
Growth-phase MC3T3-E1 clone-4 cells were grown to
>90% confluency and co-transfected with Firefly Lu-
ciferase test constructs and SV40-Renilla constructs using
Lipofectamine (Invitrogen, Life Technologies, Grand Is-
land, NY) and Plus Reagent (Invitrogen, Life Technologies,
Grand Island, NY) according to manufacturer’s instruc-
tions. 2.5 g of total plasmid DNA was transfected per 60
mm plate as described in the Results section. At designated
days post-switch, cultures were harvested and reporter ac-
tivities were measured using the Dual-Luciferase Reporter
Assay System (Promega, Madison, WI) on a VICTOR X4
Multilabel Plate Reader (Perkin Elmer, Waltham, MA) ac-
cording to manufacturers’ instructions. Each test condition
described is represented by at least nine replicate plates, and
statistical significance values are reported where applicable.
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Interplasmid 3C
We adapted a 3C-qPCR (31) approach for analyz-
ing the interaction frequency between two transiently
co-transfected plasmid constructs. We have named
this method interplasmid 3C (i3C). The follow-
ing primers were designed to span SphI restriction
sites: TOPO 5′-GCACGTACTCGGATGGAAG-3′,
pGL3 5′-CCGAGTGTAGTAAACATTCCAAAAC-
3′, Runx2 internal control FW 5′-
CTCTTCATTTGCACTGGGTCACACG-
3′ and Runx2 internal control RV 5′-
CCAGGGAAGTGGAGGGAAGGGTTG-3′. qPCR
was performed as described above. Enrichment of ligation
products was assessed by normalizing the Ct values of
the 3C-ligation products to an internal loading control.
Relative ligation frequency was obtained by normalizing
the enrichment values to the empty TOPO–empty pGL3
control combination. Student’s t-test was used to assess the
P values.
RESULTS
Identification of a long-range interaction between theRunx2-
P1 and Supt3h promoters
In order to assess the prevalence of long-range looping in-
teractions between Runx2-P1 and Supt3h promoters in a
variety of cellular contexts, we examined (using the WashU
Epigenome Browser (20)) publicly available HiC and ChIA-
PET datasets that are part of the ENCODE project (see
the Materials and Methods section). Because DHS and
CTCF are strongly correlated with the presence of long-
range interactions (32), we decided to include these marks
in our analysis. In addition, RNA-seq and PolII ChIP-seq
data were included as parameters of transcriptional activ-
ity. HiC (high-throughput chromosomal conformation cap-
ture) methodology probes long-range chromosomal inter-
actions on a genome-wide scale (33). ChIA-PET (Chro-
matin InteractionAnalysis by Paired-End Tag Sequencing),
on the other hand, identifies chromatin interactions at re-
gions associated with a transcription factor or a complex of
interest via a combination of chromatin immunoprecipita-
tion (ChIP) and 3C mapping (34).
IMR90 human lung fibroblasts display a long-range in-
teraction between Runx2-P1 and Supt3h promoter regions,
which are∼38 kb away from each other (Figure 1a). Results
from individual IMR90 HiC experimental replicate tracks
show the same result (Supplementary Figure S1a). More-
over, RNA-seq data suggest that the Supt3h gene is tran-
scribed. Consistent with the observation of the chromatin
interaction, the Supt3h promoter also harbors DHS, CTCF
and PolII binding. There is no detectable RNA-seq signal
at the Runx2-P1 promoter region, as expected from a non-
osteogenic cell line (Figure 1a).
In K562 leukemia cells, ChIA-PET data for interactions
bound by PolII demonstrate many looping interactions
within the intervening sequences between Runx2-P1 and
Supt3h promoters, as indicated by the different sizes of arcs
in Figure 1b. Comparison of data from individual repli-
cates suggests that the variability of detectable interaction
events within this region is fairly high (Supplementary Fig-
ure S1b). However, the interaction between the Runx2-P1
and Supt3h promoter regions is reproducible between these
two replicates (Supplementary Figure S1b). The epigenetics
marks correlating with higher-order chromatin organiza-
tion such as the presence of DHS, enrichment of CTCF and
PolII, and a strong RNA-seq peak are all observed in the
Supt3h region. Similar to the case in IMR90 cells, there is
no detectable ChIP-seq or RNA-seq signal in theRunx2-P1
promoter (Figure 1b). Interestingly, the intensity and loca-
tions of the looping interactions in K562 cells greatly differ
between the Runx2 and Supt3h promoter regions. This may
be due to PolII tracking through the Supt3h gene body dur-
ing active transcription. It is worth noting that the Supt3h
promoter region also makes long-range interactions with
regions other than the Runx2-P1 promoter, suggesting a
complex regulatory interaction network for these genes.
ChIA-PET data for MCF7 PolII also suggest a physical
interaction between Runx2 and Supt3h promoter regions,
accompanied by a DHS, transcription of the Supt3h gene,
and PolII and CTCF binding to the Supt3h promoter (Fig-
ure 1c). There is no transcription detected from the Runx2-
P1 promoter. In comparison with the K562 PolII ChIA-
PET data, looping between the Supt3h promoter and other
regions is observed in addition to many local interactions in
MCF7 cells. In this dataset, the interaction betweenRunx2-
Supt3h is detected in only one of the two experimental repli-
cates, which might indicate contacts are rare inMCF7 com-
pared to K562 cells.
Because there is a long-range interaction betweenRunx2-
Supt3h promoters in human cell lines that lack detectable
Runx2-P1 driven transcription as assessed by RNA-seq
tracks, we next asked whether this interaction also exists
in a murine cell line where Runx2 is silent. In order to ad-
dress this question, we used the 3C approach (25,26) to ex-
amine the RAW 264.7 murine macrophage cell line, which
exhibits low levels of Runx2 expression as assessed by RT-
qPCR (Supplementary Figure S2).
3C is a widely used method that employs the intra-
molecular ligation of enzymatically digested cross-linked
chromatin. Unique ligation junctions are quantified by
PCR to assess the relative proximity of restriction fragments
of interest to detect captured interacting chromosomal do-
mains (25,26). We analyzed the interaction profile of the
Runx2-P1 promoter with the BglII restriction fragments en-
compassing the Supt3h and Runx2-P2 promoters (Figure
1d). The 3C primers were designed to query the ligation fre-
quency between the anchor fragment located at the P1 pro-
moter and BglII restriction fragments flanking the Supt3h
and Runx2-P2 promoter regions (see Supplementary Table
S1 for the primer list).
Similar to the cases observed in different human cell
lines that have minimal Runx2 expression (Figure 1a–c), we
found long-range interactions between the Runx2-P1 and
Runx2-P2 regions, and between Runx2-P1 and the Supt3h
promoters (Figure 1d).
Taken together, these findings suggest that the Runx2-P1
and Supt3h promoters are in close proximity in four dif-
ferent cell types of human and mouse origin. The human
cell lines queried show the presence of DHS, and the en-
richment of CTCF and PolII at the Supt3h promoter. The
presence of DHS and the enrichment of CTCF at this re-
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Figure 1. (a) WashU Epigenome Browser snapshot of the HiC interaction frequencies in IMR90 cells (22) between the Runx2-P1 and Supt3h promoter
regions. The genes are diagramed on top, and the transcriptional start sites are indicated by the arrows. The 20-kb regions encompassing the Runx2-P1
and Supt3h promoters are highlighted with black bars. In the HiC heatmap, darker colors represent higher interaction frequency. UCSC genome browser
screenshots of ChIP-seq profiling signal tracks for PolII, CTCF, DHS and RNA-seq data of IMR90 cells are labeled. (b, c) ChIA-PET interactions bound
by PolII within the local Runx2-P1 and Supt3h promoter regions, accompanied by UCSC genome browser screenshot of PolII and CTCF ChIP-seq, DHS
and RNA-seq signals for K562 (b) and MCF7 (c) cells. The arrows indicate the specific interaction between Runx2 and Supt3h promoter regions. (d)
Chromosome conformation capture (3C) analysis of theRunx2 gene locus in RAW 264.7 macrophages. The x-axis represents the genomic position and the
y-axis shows the relative interaction frequency. Anchor BglII fragment at Runx2-P1 is indicated with a black bar. Gray bars indicate the BglII restriction
fragments. Arrowheads point at the Supt3h and Runx2-P2 interactions. Error bars: S.E.M.
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gion correlate with the observation of the long-range in-
teraction (32,35). In the mouse RAW 264.7 macrophage
cells, in which the Runx2 gene is transcriptionally silent,
the same interaction is also observed via 3C analysis. These
findings suggest that these interactions represent a static
three-dimensional structure established between theRunx2-
P1 and Supt3h promoters in cells that have minimal levels
of Runx2-P1 driven transcription.
Interaction frequency between Runx2-P1 and Supt3h pro-
moters is increased during osteoblast differentiation
Runx2 is fundamental for bone formation and mainte-
nance. Because Runx2-P1 driven transcription increases
during osteogenesis (12,36), we asked whether the long-
range association observed between the Runx2-P1 and
Supt3h promoters is altered during osteoblast differenti-
ation. We compared the MC3T3-E1 cell line at growth
phase, pre-osteoblasts (d0) versus differentiating cultures
at matrix-deposition stage (d9), as Runx2 transcript lev-
els have been shown to increase ∼2–6-fold by the matrix-
deposition stage of osteoblastogenesis (37,38). This marked
increase in transcription occurs within the first 9 days of dif-
ferentiation.
Using the 3C methodology, we queried the interaction
profile of the Runx2-P1 promoter with sequences flanking
∼300 kb 5′ and 3′ of this promoter in d0 and d9 cultures. The
3C results show that the Runx2-P1 anchor fragment dis-
plays high-interaction frequency with the fragment encom-
passing the Runx2-P2 promoter in both d0 and d9 cultures
(Figure 2a). Cells cultured in differentiation conditions for
d9 show a modest, statistically insignificant increase in the
interaction frequency between theRunx2-P1 andRunx2-P2
promoters. A notable interaction between the anchor frag-
ment and the fragment encompassing the Supt3h promoter
in d0 cultures was also observed. Interestingly, there was a
statistically significant ∼2-fold increase (P < 0.05) in inter-
action frequency at this region in d9 versus d0 cultures (Fig-
ure 2a). Interaction with the Supt3h promoter region was
among the most significantly changed throughout the en-
tire 600-kbRunx2 locus during differentiation, suggesting a
mechanistic link with the conserved syntenic nature of these
genes.
To confirm the interactions between the Runx2-P1,
Supt3h, and Runx2-P2 promoter regions in differentiating
(d9) osteoblasts, we utilized the 3C primer that is most prox-
imal to the Runx2-P2 promoter as the anchor primer to
probe for interactions between theRunx2-P2 promoter and
flanking regions. When the BglII fragment spanning the
Runx2-P2 promoter is used as the anchor, strong interac-
tion frequencies with bothRunx2-P1 and Supt3h promoters
are observed (Figure 2b).
To further validate these results, we repeated the 3C ex-
periments with an alternative design, using the HindIII re-
striction enzyme instead of BglII. Interaction frequencies
between the anchor Runx2-P1 fragment and the HindIII
fragments at the Supt3h promoter region were analyzed in
d0 and d9MC3T3 cells. We observed that the HindIII frag-
ment at the Supt3h TSS region has a significantly higher
interaction frequency with the Runx2-P1 promoter in d9
cultures than in d0 cultures (Supplementary Figure S3). It
is also worth noting that the looping HindIII and BglII
fragments (Figure 2a) at the Supt3h promoter overlap with
each other. HindIII fragments flanking the BglII fragment
showed similar interaction frequencies in d0 and d9 cultures
(Supplementary Figure S3).
The increase in chromatin association between the
Runx2-P1 and Supt3h promoters during differentiation
suggests a possible regulatory relationship between these
two regions, while other interaction events appear to remain
constant.
Interactions between Runx2-P1 and Supt3h are enriched for
CTCF, RUNX2 and DHS during osteoblast differentiation
Genome-wide studies have recently shown that many devel-
opmentally regulated genes exhibiting long-range interac-
tions are enriched for CTCF (32,35). Additionally, RUNX2
protein is shown to be a component of the nuclear matrix
and to act as a nuclear scaffolding factor (1,9,10). We asked
if the local chromatin state is altered at the Runx2-P1 and
Supt3h promoter regions during differentiation, in which
the looping intensity is significantly increased upon differ-
entiation.
We have recently employed a comparative analysis of
the genome-wide enrichments of CTCF and RUNX2 via
ChIP-seq during MC3T3-E1 differentiation (38). To deter-
mine whether the interactions between the Runx2-P1 and
the Supt3h promoter regions correlate with the recruitment
of CTCF and/or RUNX2, we extracted the ChIP-seq data
encompassing the Runx2 locus. Additionally, to address
whether there is altered nucleosome association at these re-
gions due to a change in factor occupancy, we carried out
DNase-seq experiments in differentiating MC3T3 cultures
(Figure 3) (40).
Interestingly, the DHS profile of the genomic region sur-
rounding theRunx2-Supt3h gene locus shows the most pro-
nounced peak at the Supt3h promoter region in both d0 and
d9 cultures. ChIP-seq analysis demonstrates that CTCF,
which is implicated in mediating long-range interactions,
is enriched at the Supt3h promoter on d0, consistent with
the basal level of interaction in cells that lack Runx2-P1
activity. As pre-osteoblasts undergo osteoblast differentia-
tion, we also observed a modest increase of CTCF enrich-
ment at the Supt3h and Runx2-P1 promoters (d9), coincid-
ing with a similar increase in the DHS signal at this region
(Figure 3). Interestingly, the timing of enrichment of CTCF
at the Supt3h promoter overlaps with the increased looping
frequency with Runx2-P1 (Figure 2a). Moreover, ChIP-seq
data demonstrate that RUNX2 enrichment is substantially
increased at the Runx2-P1, Runx2-P2 and Supt3h promot-
ers upon differentiation (Figure 3).
The increase of DHS and CTCF enrichment at the
Supt3h promoter, together with the differentiation-
dependent increased looping frequency, suggests a mech-
anistic link between the Supt3h and Runx2-P1 promoters.
The enrichment of RUNX2 observed at both Runx2-P1
and Supt3h promoters is correlated with the increase in
transcriptional activity of the bone-related Runx2-P1
promoter (12), implying a regulatory role for sequences
within the Supt3h promoter.
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Figure 2. 3C analysis of Runx2-P1 promoter. (a) 3C analysis of the Runx2 locus in proliferating (d0 and d9) post-differentiation MC3T3-E1 cultures. The
genes are diagramed on top, and the TSSs are designated by the arrows whereas the exons are represented by black bars. The anchor fragment is designated
by a black bar at Runx2-P1. The x-axis represents the genomic position and the y-axis shows the relative 3C interaction frequency. The highest interaction
frequency value (d9, Runx2-P2 peak) was normalized to 1. Error bars: S.E.M. (b) 3C analysis of d9 MC3T3 cultures with the anchor fragment located on
Runx2-P2. The black arrows point at Runx2-P1 and Supt3h regions. Error bars: S.E.M. (*P < 0.05 by Student’s t-test).
Supt3h expression levels remain constant during osteoblast
differentiation
As the Supt3h promoter region undergoes alterations in
chromatin conformation, DHS and factor binding profiles,
we analyzed the expression of Supt3h throughout several
time points during osteoblast differentiation. As expected
(39), transcript levels ofRunx2-P1 andRunx2-P2 increased
between d0 and d9 cultures (2.5-fold and 1.6-fold, respec-
tively) (Figure 4a). mRNA levels of bone-sialoprotein (ibsp)
and osteocalcin (bgalp2), markers for osteoblast differen-
tiation, were increased several-fold between the same two
time points (Figure 4a) while the supt3hmRNA levels were
relatively unchanged. In order to rule out the possibility
that supt3h mRNA levels might fluctuate between d0 and
d9, we measured the supt3h expression levels at additional
time points during differentiation. Cultures harvested be-
tween d2 and d7 after initiation of differentiation showed no
significant changes in supt3h RNA levels (Figure 4b). This
lack of change in RNA levels is also true of cultures under-
going mineralization for 28d post-differentiation (data not
shown). Therefore, despite changes in the local chromatin
architecture of its promoter (Figures 2a and 3), supt3h ex-
pression was not changed during osteoblastic differentia-
tion.
Runx2-P1 and Supt3h promoters can physically interact and
regulate Runx2-P1 expression in-trans
The increase ofRunx2-P1 andSupt3h interaction frequency
as well as the enrichment of RUNX2 and presence of DHS
at the Supt3h promoter, without affecting Supt3h expres-
sion, suggests that regulation of theRunx2-P1 promoter in-
cludes chromatin alterations that do not affect Supt3h gene
transcription.
To determine if the Supt3h promoter region can regulate
the transcriptional activity of the Runx2-P1 promoter, we
generated a reporter construct by cloning a ∼3-kb Supt3h
fragment (−1154 to +1915 of the Supt3h TSS) upstream of
a ∼1-kb (−965 to −16) Runx2-P1 promoter sequence that
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Figure 3. The epigenetic landscape of the Runx2 locus during differentiation. DNaseI-seq and ChIP-seq signal tracks for CTCF and RUNX2 enrichment
in d0 and d9 MC3T3s. The DHS scores for the Supt3h promoter region are also shown.
drives the luciferase reporter gene (40). The 3-kb Supt3h
fragment partially overlaps with the looping BglII fragment
(Figure 2a). Luciferase reporter assays were conducted in
undifferentiated (d0) and post-differentiated (d6) MC3T3-
E1 cultures.We observe that the 3-kb Supt3h promoter con-
struct suppresses the transcriptional activity of the Runx2-
P1 promoter in both d0 and d6 cultures (Figure 5a). Similar
effects were observed when different fragments within the
upstream 2.5 kb of the Supt3h promoter were assayed for
reporter gene expression (Supplementary Figure S4). Some
of the regions tested also include the DNaseI hypersensitive
site in Figure 3.
Taking into account the increase in Runx2-P1 transcrip-
tion by∼3-fold in d9MC3T3 cultures (Figure 4a) accompa-
nied by the increase in looping interaction frequency (Fig-
ure 2a), the suppressive effect on luciferase reporter activ-
ity of the Supt3h promoter was unexpected. We therefore
reasoned that the transcriptional effect ofRunx2-P1we ob-
served with the different Supt3h promoter regions might be
related to undefined spacing requirements for these regula-
tory sequences. When these regions are placed in tandem in
the same plasmid (in-cis), they are in an artificial configu-
ration removed from their endogenous context. Therefore,
to better recapitulate the endogenous context, we asked
whether Runx2-P1 and Supt3h promoter regions could reg-
ulate Runx2-P1 transcription while residing on different
plasmid constructs via an in-trans association.
To test whether the Supt3h promoter region can physi-
cally interact with and regulate the Runx2-P1 promoter ac-
tivity in-trans, we employed a modified 3C assay that we
have named ‘i3C’ (Figure 5b). In the i3C method, as sum-
marized in Figure 5b, we used the (−965 to −16) Runx2-
P1 promoter pGL3 luciferase construct, and we also cloned
the 3.3-kb Supt3h promoter region (−1154 to +1915) into a
TOPO plasmid to generate the Supt3h-TOPO construct.
MC3T3-E1 cultures were co-transfected with the Runx2-
P1 pGL3 luciferase construct along with the Supt3h-TOPO
construct to test if they associate with each other. Paral-
lel cultures were co-transfected with the Runx2-P1 pGL3
luciferase construct along with an empty-TOPO plasmid
to serve as a negative control, and the empty pGL3 lu-
ciferase construct along with the empty-TOPO construct
to serve as a normalization control for the i3C experiment.
The Supt3h–TOPO vector combination was also added as
a control. After co-transfection, cells were differentiated for
5 days and treated in the same manner as cultures subjected
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Figure 4. qPCR analysis of bone-specific genes during osteoblast differentiation. (a) Relative expression levels of runx2-P1, runx2-P2, ibsp, bglap2 and
supt3h in d0 and d9 cultures. Relative expression was normalized to ‘d0’ values. (b) Time course qPCR expression analysis of bone-related genes in d0, d2,
d4, d5, d6 and d7. (*P < 0.05 by Student’s t-test).
to the 3Cmethodology (see theMaterials andMethods sec-
tion). To assess the ligation frequency between the plasmids,
PCR quantification was performed with i3C primers spe-
cific to either pGL3 or TOPO plasmid backbone sequences.
Our results reveal that when normalized to the empty
pGL3 and empty-TOPO co-transfection control, d5 cul-
tures transfected with the Runx2-P1 pGL3 luciferase and
Supt3h-TOPO constructs showed a∼2.5-fold increase in in-
teraction frequency compared to the Runx2-P1 pGL3 and
empty-TOPO constructs (Figure 5c). In other words, pGL3
luciferase and TOPO constructs interact at a higher fre-
quency only when the TOPO construct contains the 3.3-kb
Supt3h region and the pGL3 constructs the Runx2-P1 pro-
moter region (Figure 5c, third and fourth lanes). Our i3C
results demonstrate that co-transfected plasmids can phys-
ically interact. More importantly, we demonstrate that the
Supt3h and the Runx2-P1 promoters on separate plasmids
can associate in-trans outside of their endogenous chromo-
somal context.
We next tested whether the Supt3h promoter region can
regulate the activity of the Runx2-P1 promoter using the
in-trans system described above. We co-transfected MC3T3
cells with theRunx2-P1 pGL3 luciferase construct together
with either Supt3h-TOPO or empty-TOPO constructs. We
then assayed for Runx2-P1 promoter activity via luciferase
reporter assay at daily intervals throughout differentiation
(d2, d4, d5, d6 and d7) (Figure 5d). Surprisingly, cultures
transfected with Supt3h-TOPO displayed a nearly 40% in-
crease in luciferase activity at d7 compared to cultures
transfected with the empty-TOPO construct (Figure 5d).
Nucleic Acids Research, 2014, Vol. 42, No. 16 10369
Figure 5. Inter-plasmid 3C and in-trans luciferase assay. (a) Luciferase reporter assay of the Supt3h construct in d0 and d6 MC3T3-E1 cells. (b) The
schematic of the interplasmid-3C assay. After the co-transfection of pGL3 and TOPO vectors, chromosome conformation capture is performed, and
the proximity of two plasmids is assessed via primers designed on the backbone of the vectors. (c) i3C analysis of co-transfected plasmids. The y-axis
represents the relative ligation frequency between the plasmids. The co-transfection of plasmids was represented with a ‘+’ below. Error bars: S.E.M.
(d) In-trans luciferase assay. Cells were transfected with either Supt3h-TOPO or empty-TOPO construct, and relative luciferase activity was measured at
indicated time points. (*P values assessed by Student’s t-test.)
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The increase in Runx2-P1 promoter activity after d6 sug-
gests that the regulatory sequences within the Supt3h pro-
moter, which exerted a suppressive effect in-cis (Figure 5a),
can positively regulate the Runx2-P1 promoter activity in-
trans in a differentiation-dependent manner.
DISCUSSION
Recentmapping of genome-wide chromosomal interactions
in both prokaryotes and eukaryotes suggests the regulatory
importance of long-range associations to control gene ex-
pression (41,42). During development, the genome under-
goes drastic structural and regulatory changes resulting in
the alteration of cell identity. RUNX2 is an important regu-
lator of bone formation and a key player in metastatic bone
disease (1–5). Perturbations to the Runx2 gene and reduc-
tion of its transcript levels result in cleidocranial dysplasia
(43). Due to its importance in development and disease, un-
derstanding the structure and the regulation of the Runx2
gene is relevant to many regulatory pathways.
Genetic evidence suggests that mammalian Runx genes
acquired the utilization of two promoters (P1 and P2) prior
to their duplication event (44). Therefore, if a regulatory re-
lationship between different sequences within the Runx lo-
cus existed before its duplication, it is possible that this re-
lationship may be conserved throughout evolution in par-
alogue Runx genes. In the light of these findings, the syn-
tenic relationship betweenRunx2 and Supt3h has prompted
us to hypothesize that an architectural and regulatory rela-
tionship exists between these promoter regions. Apart from
the syntenic relationship, the fact that theSupth3h promoter
is embedded between Runx2-P1 and P2 promoters hints at
the possibility that the Supt3h promoter sequence may have
been co-opted by the Runx2-P1 promoter as an enhancer.
Promoters have been shown to act as enhancers for other
genes (23).
During Runx gene duplication, although the syntenic
relationship with Supt3h may have been lost, the depen-
dency of an intronic enhancer may have been retained in
the Runx1 and Runx3 gene loci. Evidence for such conser-
vation of cis-regulatory elements is observed in the Runx1
gene, a paralogue ofRunx2.Runx1 has a similar gene struc-
ture to Runx2, with two isoforms transcribed from two dis-
tinct promoters. RUNX1 is required for hematopoietic cell
development. Markova et al. reported that in human lym-
phoid and erythroid cell lines, there is a higher-order loop-
ing structure between the Runx1-P1 and an intronic ele-
ment ∼35 kb downstream of this promoter (45). The dis-
tance and the localization of the intronic looping element
in the Runx1 locus coincide with the syntenic Supt3h pro-
moter in the Runx2 locus. This result is consistent with the
fact that alternative promoter usage of Runx genes existed
before their duplication (44), and it suggests the existence
of a similar structural relationship in the Runx2 gene locus.
When we queried the ENCODE database, we found that
long-range chromatin interactions exist between Runx2-P1
and Supt3h in human lung fibroblast (IMR90), breast can-
cer (MCF7) and leukemia (K562) cell lines (Figure 1). In-
terestingly, although the PolII ChIA-PET data in K562 and
MCF7 cells suggested a looping interaction between Supt3h
and Runx2 promoters, there was little to undetectable PolII
ChIP-seq signal at the Runx2-P1 promoter (Figure 1). A
similar low-level PolII signal is also observed at Runx2-
P1 in IMR90 cells. These data indicate that a basal level
of Supt3h–Runx2-P1 interaction is present regardless of
Runx2-P1 expression.
Synteny results from selective evolutionary pressure. The
selective pressure could be related to a requirement for loop-
ing events between the Runx2-P1, Runx2-P2 and Supt3h
promoter regions. These findings not only correlate with the
evolutionary relationship and the conservation of this syn-
teny acrossmany organisms, but are also consistent with the
idea of a basal structural interaction between these promot-
ers. Further evidence to support this idea comes from the
3C analysis with mouse macrophage RAW 264.7 cells (Fig-
ure 1d) and undifferentiated d0 pre-osteoblastic cells (Fig-
ure 2a). RAW264.7 cells haveminimal expression ofRunx2-
P2 and lack the expression of Runx2-P1 isoforms (Supple-
mentary Figure S2), and d0 MC3T3 cells show low levels
of Runx2-P1 activity (Figure 4a). However, we were able to
observe an interaction between the Supt3h and Runx2-P1
promoters in these cells. Moreover, we also detected a struc-
tural link between the Runx2-P1 and Runx2-P2 promoters
(Figure 2b), a phenomenon also observed in the P1 and P2
promoters of the Runx1 gene locus (45).
Another interesting finding is that the Supt3h promoter
region is epigenetically altered during differentiation, as in-
dicated by the increase in DHS and the increase of CTCF
and RUNX2 enrichment (Figure 3). However, Supt3h ex-
pression levels remain unchanged throughout this pro-
cess. The interaction frequency between the Runx2-P1 and
Supt3h promoters exhibits a striking increase during os-
teoblastic differentiation (Figure 2a). When the 3C anchor
is positioned on the Runx2-P2 promoter, the data also
suggest that three promoters (Runx2-P1, Runx2-P2 and
Supt3h) are in close proximity in d9 MC3T3 cultures (Fig-
ure 2b), a phenomenon also seen to occur in K562 cells
as assessed by the PolII ChIA-PET data (data not shown).
Taken together, our observations suggest that local changes
occurring at theSupt3h promoter act bymodulatingRunx2-
P1 activity. Alternatively, the increase of CTCF enrich-
ment may reflect the presence of an activated insulator el-
ement that flanks the Supt3h promoter region during dif-
ferentiation. The recruitment of CTCF to the Supt3h pro-
moter region may also act to prevent the regulatory ac-
tion of upstream sequences that may interfere with Supt3h
transcription. Moreover, at d0, RUNX2 binds primarily to
P2, but not to the P1 promoter. The RUNX2 protein is
known to interact and co-bind to DNA with several other
co-factors such as C/EBP (38,46,47). It is possible that
differential binding of co-factors to RUNX2 may change
its affinity for its binding sites. Additionally, the Runx2-P1
promoter contains binding sites for C/EBP, OCT1, AP-
1, RUNX2, MSX2/DLX3/DLX5, ATF, HLH/TWIST,
VDRE, LEF/TCF, NKX, NF-1, SP1 and ETS. Combina-
torial binding of these factors may also play roles in selec-
tively recruiting RUNX2 to these promoters.
We also demonstrate that the interaction between the
Runx2-P1 and Supt3h promoters impacts the activity of the
Runx2-P1 promoter. We chose to include the −965/−16
region of the Runx2-P1 promoter, as this region has been
shown to adequately respond to differentiation conditions
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(40). Also, there are three RUNX binding sites within the 5′
UTR of the Runx2-P1 promoter centered at +31, +39 and
+49 bp downstream of the Runx2-P1 TSS. These RUNX
motifs have been shown to suppress Runx2 expression as
part of a negative feedback loop (30). Luciferase reporter
assays with different Supt3h constructs cloned in-cis up-
stream of theRunx2-P1 promoter driving luciferase showed
a reduction of Runx2-P1 activity (Figure 5a). Because the
Supt3h and Runx2-P1 promoter regions reside more than
35 kb away from each other in their endogenous context,
we hypothesized that testing these regions in a ‘trans’ con-
figuration would better recapitulate the regulation occur-
ring in the endogenous setting. We therefore measured the
effect of the Supt3h promoter on the Runx2-P1 promoter
while on separate plasmids. Although the ability for regu-
latory regions residing on separate plasmid constructs to
modulate activity in-trans has been demonstrated previ-
ously (48,49), the majority of in vitro assays that test for
enhancer–promoter interactions are performed within the
same DNA construct, in cis, where the enhancer is cloned
5′ to the promoter. Functional assays aimed to validate
long-range, cis-acting interactions are also performed in
this manner. To test our hypothesis that the Supt3h pro-
moter could interact with Runx2-P1 when introduced on
separate plasmids, we utilized a modified 3C protocol that
we termed ‘i3C’ (Figure 5b). i3C results show that there is
a ∼2.5-fold higher interaction frequency between plasmids
containing the Runx2-P1 and Supt3h sequences than con-
trol plasmids (Figure 5c). This result indicates that regu-
latory sequences of the Supt3h promoter need to be at a
distance from the Runx2-P1 promoter. Under these same
conditions, when Runx2-P1 promoter driven luciferase ac-
tivity was assayed throughout differentiation, a significant
increase is observed (Figure 5d) when co-transfected with
the Supt3h-TOPO construct but not the empty-TOPO con-
struct, suggesting a differentiation-dependent activator role
of the Supt3h promoter.
It is still not clear why background levels of structural
interactions between these two promoters exist in cells
that lack Runx2-P1 transcription. However, we have shown
a bone-differentiation-specific regulatory function of the
Supt3h promoter region on Runx2-P1 promoter driven
transcription. It is important to point out that in our 3C
analysis, we only queried a ∼±300-kb genomic region sur-
rounding the Runx2 locus (Figure 2a). Other studies have
indicated that enhancers can exert their functions from hun-
dreds, or even thousands, of kilobases away (32). It may be
that additional distant regulatory regions that are located
outside the ∼600-kb Runx2 locus become associated with
theRunx2-P1 promoter region and contribute to its regula-
tion.
Taken together, our results demonstrate a novel aspect of
Runx2 gene structure and regulation. We also demonstrate
a role forSupt3h associationwith theRunx2-P1 promoter in
modulating the bone-specific activity of the Runx2-P1 pro-
moter. Further experiments such as deletion of the Supt3h
promoter regionwill be needed to provide additional insight
into the transcriptional control of the Runx2-P1 promoter
during osteogenesis.
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